Financials

  • Market Capitalization 3.49 B
  • Employee 755
  • Founded 2006
  • CEO N/A
  • Website www.veracyte.com
  • Headquarter Delaware, United States
  • FIGI BBG001J2M542
  • Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
41.95
ratio cours/chiffre d'affaires
8.46

Related tickers

#NomPrix24h %7 jours %1M %1 an %Cap Boursière7 Derniers Jours
1543
DNLI
Denali Therapeutics Inc. - Common Stock
23.27 USD-2.06%-5.98%+1.84%+43.91%3.72 B USD
1555
TLX
Telix Pharmaceuticals Limited - American Depositary Shares
10.85 USD-2.16%-4.32%+6.37%+71.95%3.68 B USD
1596
ABCL
AbCellera Biologics Inc. - Common Shares
11.33 USD+0.44%-6.90%+98.77%+179.06%3.47 B USD
1618
GPCR
Structure Therapeutics Inc - American Depositary Shares
47.13 USD+2.66%-5.27%-1.81%+76.25%3.36 B USD

Nouvelles